# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Carcinoid tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 33 results.
Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)
Status: Recruiting
Last Changed: Aug 20, 2018
First Received: Aug 09, 2018
Disease(s): Small Intestinal Carcinoid Tumors
Intervention(s): Research of constitutional genetic alterations
Locations: Damien JOLLY, Reims, France
Natural History of Familial Carcinoid Tumor
Status: Recruiting
Last Changed: Sep 26, 2019
First Received: Mar 28, 2008
Disease(s): Carcinoid
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors
Status: Not yet recruiting
Last Changed: Apr 13, 2018
First Received: Apr 13, 2018
Disease(s): Carcinoid Heart Disease
Intervention(s): Study of the occurrence of Carcinoid Heart Disease
Locations: Hôpital Edouard HERRIOT, Institut du Cancer - Hospices Civils de Lyon, Lyon, France
Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy
Status: Not yet recruiting
Last Changed: Jul 31, 2019
First Received: Jul 31, 2019
Disease(s): Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor
Intervention(s): Lutathera
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
Status: Recruiting
Last Changed: Oct 08, 2019
First Received: May 15, 2019
Disease(s): Advanced Carcinoid Tumor, Digestive System Neuroendocrine Neoplasm, Multiple Endocrine Neoplasia Type 1, Neuroendocrine Neoplasm, Unresectable Carcinoid Tumor
Intervention(s): Everolimus, Lenvatinib
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency
Status: Recruiting
Last Changed: Nov 06, 2019
First Received: Aug 28, 2019
Disease(s): Neuroendocrine Tumor, Carcinoid Syndrome
Intervention(s): Enterade®, Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0)
Locations: Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
Status: Not yet recruiting
Last Changed: Aug 22, 2019
First Received: Aug 22, 2019
Disease(s): Small Intestinal NET, Carcinoid Heart Disease
Intervention(s): Telotristat Ethyl, Lanreotide
Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors
Status: Recruiting
Last Changed: Feb 25, 2019
First Received: Jul 11, 2016
Disease(s): Small-intestine Neuroendocrine Tumors (Carcinoid Tumors)
Intervention(s): blood sample withdrawn
Locations: Chu Reims, Reims, France
Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs
Status: Recruiting
Last Changed: Dec 20, 2018
First Received: Oct 29, 2018
Disease(s): Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea, Carcinoid Syndrome
Intervention(s): Amino Acid Based Medical Food/Drink
Locations: University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States
Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors
Status: Recruiting
Last Changed: Sep 23, 2019
First Received: Feb 02, 2018
Disease(s): Neuroendocrine Tumors, Carcinoid Tumor
Intervention(s): Nivolumab, Ipilimumab
Locations: Johns Hopkins Medical Institution, Baltimore, Maryland, United States